The Hydrogen Sulfide-Vitamin B12-Folic Acid Axis: An Intriguing Issue in Chronic Kidney Disease. A Comment on Toohey JI: "Possible Involvement of Hydrosulfide in B12-Dependent Methyl Group Transfer". Molecules 2017, 22, 582, pii: E582.
作者信息
Cianciolo Giuseppe, Cappuccilli Maria, La Manna Gaetano
机构信息
Department of Experimental, Diagnostic and Specialty Medicine (DIMES)-Nephrology, Dialysis and Transplantation Unit, St. Orsola Hospital, University of Bologna, Via G. Massarenti 9 (Pad. 15), 40138 Bologna, Italy.
出版信息
Molecules. 2017 Jul 19;22(7):1216. doi: 10.3390/molecules22071216.
Abstract
摘要
相似文献
1
The Hydrogen Sulfide-Vitamin B12-Folic Acid Axis: An Intriguing Issue in Chronic Kidney Disease. A Comment on Toohey JI: "Possible Involvement of Hydrosulfide in B12-Dependent Methyl Group Transfer". Molecules 2017, 22, 582, pii: E582.硫化氢-维生素B12-叶酸轴：慢性肾脏病中一个有趣的问题。对图希·JI的评论：“硫化氢可能参与依赖维生素B12的甲基转移”。《分子》2017年，22卷，582期，文章编号：E582 。
Molecules. 2017 Jul 19;22(7):1216. doi: 10.3390/molecules22071216.
2
Possible Involvement of Hydrosulfide in B-Dependent Methyl Group Transfer.硫化氢可能参与维生素B12依赖的甲基转移。
Molecules. 2017 Apr 5;22(4):582. doi: 10.3390/molecules22040582.
3
[Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].慢性肾功能不全患者应该用叶酸、维生素B6和维生素B12治疗吗？
Ugeskr Laeger. 2008 Mar 10;170(11):933-7.
4
5
Folic Acid and Vitamin B12 Administration in CKD, Why Not?慢性肾脏病患者的叶酸和维生素 B12 治疗，何乐而不为？
Nutrients. 2019 Feb 13;11(2):383. doi: 10.3390/nu11020383.
6
7
[The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].[透析患者高同型半胱氨酸血症的治疗：叶酸还是高流量聚砜膜？]
Acta Med Croatica. 2006 Jun;60(3):201-8.
8
[The concentrations of homocysteine, folic acid and vitamin B12 in alcohol dependent male patients].[酒精依赖男性患者体内同型半胱氨酸、叶酸和维生素B12的浓度]
Psychiatr Pol. 2004 Sep-Oct;38(5):947-56.
9
Significantly higher frequencies of hemoglobin, iron, vitamin B12, and folic acid deficiencies and of hyperhomocysteinemia in patients with Behcet's disease.白塞病患者的血红蛋白、铁、维生素 B12 和叶酸缺乏症以及高同型半胱氨酸血症的频率明显更高。
J Formos Med Assoc. 2018 Oct;117(10):932-938. doi: 10.1016/j.jfma.2018.04.007. Epub 2018 Apr 30.
10
Hemoglobin, iron, vitamin B12, and folic acid deficiencies and hyperhomocysteinemia in Behcet's disease patients with atrophic glossitis.贝赫切特病萎缩性舌炎患者的血红蛋白、铁、维生素 B12 和叶酸缺乏及高同型半胱氨酸血症。
J Formos Med Assoc. 2018 Jul;117(7):559-565. doi: 10.1016/j.jfma.2018.03.005. Epub 2018 Mar 21.
引用本文的文献
1
Vitamin B Supplementation and Nutritional Intake of Methyl Donors in Patients with Chronic Kidney Disease: A Critical Review of the Impact on Epigenetic Machinery.维生素 B 补充和慢性肾脏病患者甲基供体的营养摄入：对表观遗传机制影响的批判性综述。
Nutrients. 2020 Apr 27;12(5):1234. doi: 10.3390/nu12051234.
2
Folic Acid and Vitamin B12 Administration in CKD, Why Not?慢性肾脏病患者的叶酸和维生素 B12 治疗，何乐而不为？
Nutrients. 2019 Feb 13;11(2):383. doi: 10.3390/nu11020383.
本文引用的文献
1
Possible Involvement of Hydrosulfide in B-Dependent Methyl Group Transfer.硫化氢可能参与维生素B12依赖的甲基转移。
Molecules. 2017 Apr 5;22(4):582. doi: 10.3390/molecules22040582.
2
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.叶酸治疗对慢性肾脏病进展的疗效：中国脑卒中一级预防试验的肾脏子研究。
JAMA Intern Med. 2016 Oct 1;176(10):1443-1450. doi: 10.1001/jamainternmed.2016.4687.
3
Lower Hydrogen Sulfide Is Associated with Cardiovascular Mortality, Which Involves cPKCβII/Akt Pathway in Chronic Hemodialysis Patients.低硫化氢水平与心血管死亡率相关，这涉及慢性血液透析患者中的cPKCβII/Akt信号通路。
Blood Purif. 2015;40(3):260-9. doi: 10.1159/000439580. Epub 2015 Oct 7.
4
Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy.糖尿病肾病慢性血液透析患者中低浓度硫化氢与动脉粥样硬化的相关性
Blood Purif. 2014;38(3-4):188-94. doi: 10.1159/000368883. Epub 2014 Dec 16.
5
The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.降低同型半胱氨酸的B族维生素在心血管疾病一级预防中的作用。
Cardiovasc Ther. 2014 Jun;32(3):130-8. doi: 10.1111/1755-5922.12064.
6
US Renal Data System 2013 Annual Data Report.美国肾脏数据系统2013年度数据报告。
Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7. doi: 10.1053/j.ajkd.2013.11.001.
7
Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.更新高同型半胱氨酸血症降低治疗与心血管事件的关系。
Cardiovasc Ther. 2013 Aug;31(4):e19-26. doi: 10.1111/1755-5922.12014.
8
Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study.高同型半胱氨酸血症与基于人群的 CoLaus 研究中的白蛋白尿独立相关。
BMC Public Health. 2011 Sep 26;11:733. doi: 10.1186/1471-2458-11-733.
9
Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy.βIIPKC 的药理学抑制在晚期肥大中具有心脏保护作用。
J Mol Cell Cardiol. 2011 Dec;51(6):980-7. doi: 10.1016/j.yjmcc.2011.08.025. Epub 2011 Sep 2.
10
The gasotransmitter hydrogen sulfide in hemodialysis patients.血液透析患者中的气体递质硫化氢。
J Nephrol. 2010 Nov-Dec;23 Suppl 16:S92-6.
Zotero 插件